Agilon Health, Inc. (AGL) Revenue Growth
Agilon Health, Inc. (AGL) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | 30.25% |
| 2023-12-31 | 80.74% |
| 2024-12-31 | 40.41% |
| 2025-12-31 | -2.11% |
How AGL compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| HSIC | Henry Schein Inc. | 4.03% |
| DHR | Danaher Corporation | 2.90% |
| BMY | Bristol-Myers Squibb Company | -0.22% |
| AMPH | Amphastar Pharmaceuticals Inc. | -1.65% |
| HAE | Haemonetics Corporation | -1.97% |
These are five companies in the same sector as AGL with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Agilon Health, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("AGL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AGL | $88.50 | +2.34% | 0.13M |
| 3 | ||||
| 4 | ||||
| 5 |